Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

about

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy.

P2860

Q49878390-CBC9F95B-4DC1-4F7C-8C31-D38996C60139

P2860

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

Item

http://www.wikidata.org/entity/Q50027827

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@en

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@nl

type

Item

label

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@en

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@nl

prefLabel

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@en

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@nl

P1476

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

@en

P2093

Caitlin Stashwick

http://www.w3.org/2001/XMLSchema#string

Gabriela Plesa

http://www.w3.org/2001/XMLSchema#string

Janos L Tanyi

http://www.w3.org/2001/XMLSchema#string

Mark H O'Hara

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Adoptive T cell therapy for cancer in the clinic

P304

767-780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2017-0026

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28771103

http://www.w3.org/2001/XMLSchema#string

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

about

P2860

P2860

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698